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ABSTRACT 
Herpes simplex virus 1 (HSV-1) is one of nine different herpesvirus infecting 
man. They are all capable of establishing a life-long latent state following the 
primary infection. HSV-1 as well as other herpesviruses may reactivate from 
the latent state and give rise to a productive infection with clinical symptoms 
or asymptomatic shedding. HSV-1 infections are primarily treated by 
targeting the viral DNA replication carried out by a molecular machinery, a 
replisome, encoded by the virus. Here we examine the mechanism of 
initiation of viral DNA replication and also how viral DNA replication 
interacts with DNA recombination and gene expression.  
In our first study we examined the initiation-step of HSV-1 replication. The 
origin binding protein (OBP) initiates replication by binding to the origin of 
replication (oriS and/or oriL). We showed, using phylogenetics and 
biochemical experiments, that there was a step-wise evolutionary 
development of herpesvirus DNA replication initiation. The initial divergence 
was seen in herpesviruses acquiring an amino-acid motif RVKNL in OBP 
which binds the sequence TTCGCAC in the oriS. The next step was the 
development of an ICP8 binding motif at the C-terminus of OBP and finally 
the arrangement of the binding-sites for OBP in the oriS-sequence and the 
ability to form a stable hairpin. We presented molecular in vitro data to 
support the phylogenetic analysis and thereby defining essential motifs in 
OBP for protein-protein and protein-DNA interactions. 
The next study was focused on genetic recombination between different 
HSV-1 strains. We followed the propagation of HSV-1 in cells infected with 
one to three genotypes of HSV-1 and calculated the number of recombination 
events. We found evidence for Rad51 and Rad52 involvement in 
recombination of the unique long and unique short gene segments of HSV-1. 
We also observed an increased recombination rate in cells with retarded 
ligation of Okazaki-fragments. The fidelity of recombination in virus 
propagated through mixed infections appears to be high since expansion or 
shortening of repeated sequences in the US7 gene was not detected. 
In the third study we examined the replication-coupled transcription of 
HSV-1 late genes, which are known to depend on DNA replication for 
efficient expression. Using chromatin immuno-precipitation we could 
determine that recruitment of RNA polymerase II to late gene promoters 
occur even in the absence of replication. Recruitment was dependent on 
ICP4, but delayed in comparison with early gene promoters. These 
observations suggested the involvement of transcription elongation and/or 
maturation in the expression of gamma genes. By using the drug DRB, which 
inhibits the kinase CDK9, a component of the positive transcription 
elongation factor B, and siRNA against Spt5, a transcription processivity 
factor, we could show a specific impairment of late gene expression, with 
only minimal effect on early gene expression and DNA synthesis. We 
suggest that CDK9 and Spt5 are specifically recruited to replicated late genes 
and mediate a maturation of transcribed mRNA for nuclear exit. 
In summary, we have studied essential molecular processes in the HSV-1 life 
cycle and identified molecular interactions as well as mechanistic pathways, 
which may serve as future drug targets. 
Keywords: Herpes Simplex Virus 1, DNA replication, DNA recombination, 
Rad51, Rad52, Transcription, CDK9, Spt5 
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SAMMANFATTNING PÅ SVENSKA 
Herpes Simplex Virus 1 (HSV-1) är ett av nio herpesvirus som infekterar 
människor. De kan alla etablera ett livslångt latent stadium efter primär 
infektion. Herpesvirus kan därefter reaktiveras från det latenta stadiet och ge 
kliniska symptom eller utsöndras asymptomatiskt. HSV-1 infektioner 
behandlas med läkemedel som angriper maskineriet som replikerar viralt 
DNA. Vi har studerat mekanismer för initiering av viral DNA replikation 
samt hur viral DNA replikation interagerar med DNA rekombination och 
genexpression. 
I det första arbetet studerade vi det första steget i replikationen, initiering via 
interaktion mellan det virala proteinet OBP och sekvensen oriS. Vi kunde 
med hjälp av fylogenetiska studier och in vitro-försök visa hur denna process 
stegvis har utvecklats under evolutionen. Både aminosyra-motiv, interaktion 
med andra proteiner i replikationsmaskineriet samt sekvensarrangemanget i 
oriS har varit essentiella i utvecklandet av denna initierings-process. 
I det andra arbetet analyserade vi DNA rekombination vid infektioner med 
olika typer av HSV-1. Genom att använda oss av markörer räknade vi fram 
hur ofta rekombination sker. Resultaten visade att Rad51 och Rad52 är 
delaktiga i rekombination av virussegmenten UL och US. Vi visade även att 
rekombination sker oftare i celler med förlångsammad ligering av Okazaki-
fragment. Noggrannheten vid rekombination med olika typer av virus visade 
sig vara hög då ett repetitivt område i genen US7 förblev oförändrat.  
I det tredje arbetet studerade vi replikationskopplad transkription av HSV-1 
sena gener som kräver DNA replikation för effektivt uttryck. Vi visade att 
rekrytering av RNA polymeras II till sena geners promotor sker trots 
avsaknad av DNA replikation. Rekryteringen kräver dock ICP4 och är 
förlångsammad i förhållande till tidiga gener. Detta ledde oss till att studera 
mRNA-mognad med hjälp av en inhibitor, DRB som blockerar funktionen av 
kinaset CDK9, en positiv elongeringsfaktor, samt med siRNA mot Spt5, en 
processivitetsfaktor. Vi kunde med dessa två metoder förhindra sent 
genuttryck med minimal påverkan på tidigt genuttryck och DNA replikation. 
Vi föreslår därför en modell där CDK9 och Spt5 rekryteras till sena gener 
som genomgått DNA replikation. 
Sammantaget har vi studerat essentiella mekanismer under HSV-1 
proliferativa stadium som kan vara viktiga mål för framtida 
läkemedelsutveckling. 
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DRB 5,6-Dichlorobenzimidazole 1-β-D-ribofuranoside 
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1 INTRODUCTION 
1.1 Herpes Simplex Virus 1 
1.1.1 Clinical manifestations of disease 
The recurring oral symptoms caused by herpes simplex virus have been 
described in ancient scriptures. But it was not until the 1930s that it was 
proven that the recurring lesions occurred in patients which already had 
neutralizing antibodies against HSV-1 [1]. Besides causing these common 
oral lesions HSV-1 may also cause severe encephalitis. Such untreated 
patients suffer a 70% mortality and the majority of patients do not regain full 
neurological function [2]. Other clinical manifestations include genital 
lesions, gingivostomatitis, neonatal infection, keratoconjunctivitis, eczema 
herpeticum, paronychia, erythema multiforme and facial paralysis [3]. 
1.1.2 Phylogeny 
HSV-1 is classified into the order of Herpesvirales which contains viruses 
that infect a diverse variety of organisms from oysters to humans (Figure 1) 
[4]. The mammalian viruses all belong to the family of Herpesviridae and 
they are subdivided on the basis of their biological properties into the 
subfamilies alpha-, beta- and gamma-herpesvirinae. Common for all the nine 
human herpesviruses is that after an initial infection in an epithelial cell the 
viruses establish latency in a particular subset of cells. For alphaherpesvirinae 
latency is established in neuronal cells, betaherpesvirinae latency is 
established in secretory glands, lymphoreticular cells and in the kidney, and 
for gammaherpesvirinae, latency is established in lymphocytes [3]. 
Reactivation of latent virus is thought to be a balance between the viral 
properties and the immunological system which keeps the virus infected cells 
in a latent state. Therefore patients with a attenuated immune response such 
as immunosuppressed, AIDS and elderly patients have a higher degree of 
reactivation [5]. 
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Figure 1. Phylogenetic classification of Herpesvirales. Printed with permission [3]. 
1.1.3 Nomenclature of genes 
The nomenclature of HSV-1 genes is somewhat confusing. The initial steps 
towards studying the viral proteome using SDS-PAGE gels started in the 
1960’s [6]. Purification of radiolabeled virions and subsequent separation in 
polyacrylamide gels yielded 24 distinct bands which were denoted viral 
protein (VP) and a number according to their size [7]. In order to detect non-
structural viral proteins a similar approach was used to distinguish 47 bands, 
which were designated infected cell polypeptides (ICP), in cellular extracts 
from HSV-1 infected cells [8]. The present nomenclature of HSV-1 proteins 
reflect the position of the open reading frame in the unique or repeated 
sequences in the long or short region respectively (UL, RL, US, RS), however 
the old nomenclature e.g. VP16, ICP8 as well as functional description e.g. 
OBP (origin binding protein) still remains in the literature. 
1.1.4 Virus Particle 
Herpesviruses all share the common structural features. A dsDNA is packed 
into an icosahedral capsid which is surrounded by an amorphous layer called 
the tegument which is enveloped by a lipid bilayer containing glycoproteins 
(Figure 2) [9]. The average diameter of the spherical virion is 186nm with 
spikes extended to 225nm. The HSV-1 particle contains mostly virus-
encoded proteins. However, by using mass spectrometry of highly purified 
virions, 49 distinct cellular proteins were found mainly in the tegument of the 
mature virus particle [10]. 
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Figure 2. Single virion tomogram. A. Protruding glycoprotein spikes (yellow) 
anchored to the membrane (blue). B. Cutaway view of the virion interior. The capsid 
(light blue) containing the viral DNA is surrounded by the amorphous tegument 
(orange) inside the envelope (blue and yellow). pp, proximal pole; dp, distal pole. 
Scale bar, 100nm. From Grünewald 2003 [9]. Reprinted with permission from AAAS.  
The lytic life-cycle of herpesviruses (Figure 3) begins with the virus attaching 
to the cell-surface with its glycoproteins. Following de-envelopment the 
capsid is transported by microtubuli to the outer side of the nucleus where it 
injects the viral DNA into the nuclear compartment [11]. Early studies using 
radiolabeled viruses revealed that following an infection at an MOI 
(multiplicity of infection) of 20 only 35% of the radioactive DNA reaches the 
nucleus [12]. Inside the nucleus, specific compartments, ND10 (also known 
as PML nuclear bodies), form around the viral genome containing viral as 
well as host proteins [13]. The viral DNA form an endless circular structure 
by ligation of the ends by DNA ligase IV/XRCC4 shortly after entering the 
nucleus [14]. Circularization has been shown to be essential for DNA 
replication [15]. The viral program for taking over the cell begins 
immediately upon de-envelopment and involves release of tegument proteins 
and transcription of a cascade of viral genes. The sequential transcription of 
α→β→γ genes (see 1.4.5) will produce proteins for host/virus regulation, 
DNA replication and finally components for the virus particle. The newly 
formed viral DNA will be packed inside a new capsid which will exit the 
nuclear compartment by envelopment and de-envelopment. In the cytoplasm 
the capsid will acquire an envelope and exit the cell through exocytosis. The 
complete cycle in cultured cells takes approximately 20 hours [3]. 
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Figure 3. The HSV-1 lytic life-cycle. (1) Viral attachment and entry through 
fusion of the envelope with the cellular membrane. (2) Transport of capsid to 
nuclear pore. (3) Injection of viral genome into cell nucleus. (4) Sequential 
transcription of viral α→β→γ genes. (5) Assembly of viral structural proteins and 
encapsidation of viral DNA. (6) Capsid transport by envelopment and de-
envelopment of the nuclear membranes. (7) Transport of capsid to exocytic 
vesicles and acquirement of viral envelope. (8) Virus release. (Artist: Zhiyuan 
Zhao, printed with permission) 
Envelope 
More than 10 different intrinsic and extrinsic proteins are anchored to the 
lipid bilayer, most of them being glycoproteins protruding outside the virion. 
The initial step for virus approach to the extracellular matrix is by 
glycoprotein B and glycoprotein C binding to heparan sulfate of glucose-
amino-glycans [16]. Glycoprotein D will thereafter bind to the cell-surface 
proteins nectins [17]. Together with glycoprotein B, glycoprotein H and 
glycoprotein L fusion is initiated [18]. Great efforts have been made to find a 
surface antigen suitable as an effective vaccine. So far worldwide trials of a 
HSV-2 glycoprotein D vaccine have not yield desired results and a secondary 
trial with sero-negative women showed a complex picture with protection 
against HSV-1 genital infection, but no protection against HSV-2 infection 
[19]. 
Tegument 
Upon de-envelopment the tegument content is released into the cytoplasm. 
Important viral proteins such as VP16 (also known as Vmw65, α-TIF and 
UL48) and VHS (virion host shutoff, UL41) will initiate the take-over of 
the cell by initiating viral α gene transcription and degrading host cell 
mRNA respectively [20, 21]. Other tegument components will assist the 
release of viral DNA into the nucleus and selected viral/cellular transcripts 
play a role in the hostile take-over of the cell [22]. 
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Capsid 
The icosahedral structure of the capsid consists primarily of the four proteins 
VP5 (UL19), VP26 (UL35), VP23 (UL18) and VP19C (UL38) which forms 
the repeated subunits [23]. A channel through which DNA is packaged is 
formed by a dodecamer of UL6 protein [24]. 
Genome 
The 152 kb linear dsDNA genome is divided by three repetitive genomic 
elements called a-sequences, two are located at the ends and one in the 
middle. These a-sequences are bracketed by repetitive elements and the 
sequences in between these repeats are called UL and US. The arrangement of 
the UL and US elements is variable and equimolar amounts of all possible 
four combinations can be found in a virus population (Figure 4) [25]. 
 
Figure 4. The bipartite HSV-1 genome with repeated regions. Upper, the 
genome is divided into two regions, UL and US, bracketed by repeated sequences. 
TRL and TRS denote terminal repeats and IRL and IRS are internal repeats. The a-
sequence repeats (black bars) are located at the genome ends and in between the 
internal repeats. Lower, three isomeric configurations of the HSV-1 genome 
besides the top standard arrangement.  
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1.2 DNA replication 
1.2.1 E. Coli 
The initial steps towards understanding the mechanism behind DNA 
replication was through the discovery of DNA pol I in E. coli [26]. 
Subsequent studies by using e.g. enzyme fractionation and thermosensitive 
mutants have revealed a complex multi-subunit replication machinery [27]. 
According to the replicon model, DNA replication is initiated by the binding 
of an initiator protein to an origin of replication (replicator), in the case of E. 
coli the oriC [28]. The replisome is recruited sequentially and is initiated by 
the binding of a DnaA molecule to each of the five 9-mer box within the oriC 
sequence (~240 bp). By ATP-hydrolysis DnaA will unwind oriC and melt an 
AT-rich sequence upstream of the DnaA binding sites. DnaA will also recruit 
a complex consisting of a helicase, DnaB, bound to a negative regulator 
DnaC to each of the separated strand. The primase DnaG will interact with 
DnaB which will in turn dissociate DnaC from DnaB and thereby activate the 
helicase. DnaB will continuously unwind duplex DNA in a 5’→3’ direction 
and DnaG will simultaneously leave primers for synthesis of the lagging 
strand [29]. A γ-complex (consisting of five proteins; γ, δ, δ’, χ and ψ) will 
recognize primed ssDNA and load the β sliding clamp which will surround 
the ssDNA like a ring ensuring processivity. The core-complex (consisting of 
three proteins; α (DNA polymerase), ε (proofreading 3’→5’ exonuclease) 
and θ (accessory subunit)) will then bind to the loaded β-clamp. The 
simultaneous synthesis of both strands is mediated by τ-dimer which binds a 
core-complex each. The τ-dimer is bound together with a γ-dimer which will 
recruit the rest of the γ-complex subunits to form a clamp-loader on the 
lagging strand. Together these two core-complexes are bound to a τ-dimer 
and a γ-complex form the DNA polymerase III holoenzyme (pol III). The 
replication complex will proceed with a primosome melting the dsDNA and 
leaving primers on the lagging strand and the pol III following it. The pol III 
will continuously polymerise DNA on the leading strand while the core 
polymerase on the lagging strand will have to process ~1-2kb Okazaki 
fragments at a time and then disassociate from the DNA and loaded onto a 
new clamp which was put in place by the γ-complex [30]. 
1.2.2 Eukaryote 
The sequence of events leading to replication initiation in the single-cell 
eukaryote Saccharomyces cerevisiae (budding yeast) start at the 
autonomously replicating sequences (ARS, ~150 bp), containing the ACS 
(ARS consensus sequences, 11 bp) [31]. In contrast to E. coli, which only 
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contains one origin of replication (oriC), budding yeast has several hundred 
copies of ARS in order to copy the larger genome at a reasonable speed. 
According to sequence homology there are approximately 12000 ACS, of 
which approximately 400 are functional [32]. This implies that there are 
important surrounding factors that support the ACS, such as the A and B2-
element as well as nucleosomal occupancy [33]. In contrast to budding yeast, 
few origins have been discovered and no consensus sequence has been found 
for fission yeast or multicellular eukaryotes. Genome-wide studies have 
shown that human origins are associated to transcription start sites and AT-
rich regions [34]. The six-subunit initiator origin recognition complex (ORC) 
was discovered in budding yeast, but can be found in all eukaryotes [35]. In 
contrast to ORC from budding yeast, which binds sequence-specifically to 
elements in the ARS, human ORC has the ability to restore replication in 
Xenopus egg extracts where the endogenous ORC was depleted. Also, human 
ORC can initiate replication on bacterial plasmids without an human origin 
sequence with the same efficiency as plasmids containing an origin [36]. 
Following ORC-binding a pre-replicative complex will form by recruitment 
of the first replisome components, MCM 2-7, a hexameric helicase, by Cdt1 
and Cdc6 during G1-phase. S-phase CDK and Cdc7 kinase will 
phosphorylate a wide range of initiation proteins, thereamong MCM10, RP-A 
and Cdc45 which will activate the MCM helicase [37]. The unwound DNA 
will subsequently be primed by DNA polymerase α. The RNA primer will 
then be recognized by RF-C (clamp loader) which will switch the polymerase 
by recruitment of PCNA (sliding clamp) upon which the processive DNA 
polymerase δ and ε will bind. Lagging strand ssDNA will be bound by RP-A 
and Okazaki-fragments will be processed by the PCNA-bound endonuclease 
Fen-1 and ligated by DNA ligase 1 [38]. Studies using mutant polymerases 
with specific error signatures have shown that DNA polymerase ε is 
responsible for polymerization on the leading strand while DNA polymerase 
δ fills the gaps between the primers on the lagging strand [39]. Recently it 
has been suggested that polymerase δ may be responsible for replication on 
both strands and that polymerase ε may only be involved in post-replicative 
repair [40]. However, this observation still remains controversial.  
1.2.3 Model DNA virus replication 
The simian virus 40 (SV40) DNA replication has been extensively studied. 
This small (5kb) dsDNA encodes a single viral protein, T-antigen, required 
for initiation of replication. T-antigen forces the cell to enter S-phase by 
inactivating various host cell factors such as the well-known tumor 
suppressor genes p53 and Rb [41]. The origin recognized by T-antigen 
contains a palindromic array of four GAGCC pentanucleotides which is 
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flanked by an AT-rich region and an easily denatured imperfect palindrome 
[42]. Cellular replication machinery is thereafter recruited to the activated 
origin by T-antigen. A complete in vitro SV40 replication system of both 
leading and lagging strand has been reconstituted using purified T-antigen 
and the cellular proteins RPA, DNA polymerase α and δ, RFC, PCNA, 
RNAse H and DNA ligase I [43]. In a similar manner human adenovirus (22-
48kb dsDNA) induces S-phase by inhibiting p53 and Rb [44]. However, the 
DNA replication machinery consists of three viral proteins, terminal protein, 
DNA-binding protein and DNA polymerase, which synthesize continuously 
on one strand by strand displacement [45]. 
1.2.4 HSV-1 replication 
Unlike many other viruses HSV-1 DNA replication is independent of host 
cell cycle stage and the protein machinery carrying out the process is encoded 
by its own genome [3]. Temperature-sensitive mutants harbouring defective 
genes required for viral propagation were created using mutagenic chemicals. 
These could then be assigned to a complementation group and mapped to 
genomic loci such as syn [46]. Another approach to find proteins required for 
viral replication was by using a plasmid containing oriS as a reporter and 
expression plasmids encoding the genes of the replication proteins [47]. 
Seven essential replication genes (Table 1) were discovered and their 
function established by biochemical studies. It turns out one protein, the 
origin binding protein, OBP, is required for initiation of DNA replication. Six 
other proteins are necessary and sufficient for DNA replication of both 
leading and lagging [48]. 
Table 1. HSV-1 essential replication proteins. 
Name Gene Function 
OBP UL9 Origin binding protein,   
3’→5’ DNA helicase 
ICP8 UL29 ssDNA binding protein,  
interacts with OBP and 
helicase-primase 
DNA helicase-primase UL5/UL8/UL52 5’→3’ DNA helicase,       
DNA primase 
DNA polymerase UL30/UL42 5’→3’ DNA polymerase, 
3’→5’ exonuclease,               
apyrinic/apyrimidinic and 5’-
deoxyribose phosphate lyase 
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Origin of replication 
The search for the origins of replication in HSV-1 by employing electron 
microscopy revealed three origins, one in UL, between UL29 and UL30, and 
the other two within each of the bracketing repeated regions of US [49]. It 
was also shown by passage of HSV-1 at high MOI that fragments containing 
the same sequences could accumulate in virus particles [50]. By cloning in 
these fragments into reporter plasmids and through transfection and co-
infection with HSV-1 the oriS-sequence was defined. The product of this 
virally amplified reporter plasmid yielded a high molecular DNA which was 
about the same size as the viral genome itself [51]. Due to the palindromic 
sequence in the oriL-sequence bacterial amplification was not possible, but 
was later achieved in a yeast system [52]. Both origins contain palindromic 
sequences and a neighbouring AT-rich sequence (Figure 5). Mutant virus 
containing deletions of oriS or oriL sustain regular replication indicating 
overlapping function [53, 54].  
Figure 5. The HSV-1 origins. Sequence of oriS. Underlying bases in gray box 
and triangle indicate sequence differences between oriS and oriL. Arrows above 
sequence shows orientation of OBP recognition sites box I, II and III. A+T 
denotes AT-rich sequence. Printed with permission [55]. 
UL9/OBP – Origin Binding protein 
The UL9 gene encodes an 851-amino acid polypeptide, OBP, which exists as 
a homodimer and initiates DNA replication by sequence specific binding to 
the origins. OBP contains an N-terminal Superfamily II DNA helicase and 
ATPase activities. It has a C-terminal DNA-binding domain, OBP (317 
amino acids), that binds with high affinity to the consensus sequence 
TTCGCAC (Box I). Binding to Box II is ten times weaker and binding to 
Box III is only observed with full-length OBP and requires cooperative 
protein-protein interactions [54, 56, 57]. The OBP 3’→5’ DNA helicase is 
greatly enhanced by a direct interaction with ICP8 [58]. Using OBP ts-
mutants it was shown that OBP was only essential for the initiation of 
replication, but not elongation, and mutations in either conserved amino acids 
in the helicase or DNA-binding domain disrupts DNA replication [59-61]. 
OBP was shown by electron microscopy to extrude hairpins of DNA 
containing oriS [62]. Further on it was shown that OBP in the presence of 
ICP8 can specifically unwind an 80bp dsDNA containing oriS into a hairpin 
consisting of Box I and Box III. This newly formed heteroduplex termed 
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oriS* binds OBP with high affinity and increases its ATPase activity which is 
thought to denature the AT-rich sequence and pave the way for recruitment 
of other replication proteins (Figure 6) [63].  
Figure 6. Proposed model for origin activation by OBP. Dimer of OBP binds to 
oriS/oriL through C-terminal domain (circles) to BoxI and BoxII. Subsequent 
activation of origin leads to formation of a hairpin/s, oriS*/oriL*. Helicase 
(ovals) expose ssDNA which will lead to recruitment of replisome. Printed with 
permission [64]. 
UL29/ICP8 – single-strand DNA binding protein 
The gene product of UL29, ICP8, is an ATP-independent ssDNA-binding 
protein [65, 66]. Its ability to form nucleoprotein filament has been shown by 
crystallography and electron microscopy [67]. Such filaments not only 
stabilizes ssDNA for DNA replication, but they may also be substrates for 
strand-annealing in homology mediated repair-pathways, possibly in 
collaboration with UL12, a 5’→3’ exonuclease [68]. ICP8 has also been 
implied to act in a vast variety of viral pathways such as regulation of viral 
gene expression and intranuclear distribution [69, 70]. 
UL5/UL8/UL52 – DNA helicase-primase 
The helicase-primase heterotrimer consists of the protein products encoded 
by the viral genes UL5, UL8 and UL52 and exist in a 1:1:1 ratio [71]. UL5 
contains conserved helicase motifs and UL52 contains conserved primase 
motifs [72]. UL8 lacks enzymatic activity, but it is strictly required for in 
vivo replication [48]. It has been proposed to interact with several other viral 
proteins and bioinformatically characterized as an inactivated polymerase, 
however its function still remains poorly characterized [73-75]. The N-
terminal domain of UL52 binds to UL5 and the middle domain binds to UL8 
and ICP8 [76]. Functional complexes of UL5 and UL52 have been shown to 
retain their DNA-dependent ATPase as well as DNA helicase and primase 
activity in vitro [77]. Binding of ATP or GTP propels the helicase in a 5’→3’ 
direction along the template for lagging strand synthesis while the primase 
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synthesize 8-12 base long primers for extension in the lagging strand [71]. It 
is debated if the initial priming step after origin activation is carried out by 
the human DNA polymerase α and/or the HSV-1 helicase-primase, but recent 
studies have found no indication that DNA polymerase α resides on 
replicating HSV-1 DNA [78].  
Figure 7. HSV-1 replisome. Simultaneous leading and lagging strand replication 
by DNA polymerase (UL39/UL42), ssDNA binding protein (ICP8) and helicase-
primase (UL5/UL8/UL52). 
UL30/42 – DNA polymerase 
Following priming, the HSV-1 DNA polymerase, a heterodimer consisting of 
UL30 and UL42 performs replication in a theta-type bi-directional manner 
[79]. The helicase-primase interacts functionally with the polymerase and it 
may also interact directly with UL52 and/or possibly also through ICP8 and 
the C-terminus of UL8 [80, 81]. The UL30 protein, which contains the 
enzymatic polymerase activity, increases its processivity and reduces its 
dissociation rate from DNA by interaction between its C-terminal domain to 
the essential accessory protein UL42 [82, 83]. Purified UL30 has shown to 
contain intrinsic proof-reading 3’→5’ exonuclease activity and 
apurinic/apyrimidinic and 5'-deoxyribose phosphate lyase activities [84, 85].  
Structures of replication intermediates 
Following the first-round -replication the two daughter molecules will be 
separated by topoisomerase II [86]. Subsequent replication generates head-to-
tail concatemers of genomic DNA, most likely through rolling circle 
replication. This was showed by the increased concentration of DNA 
fragments containing the junction of the L and S components in relative to 
other fragments in the nucleus [87]. Efficient rolling-circle in vitro replication 
of both leading and lagging strand using primed templates have been 
achieved by using the replisome components described above (Figure 7) [48, 
88]. Electron microscopy extracted replicating HSV-1 DNA display a variety 
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of different conformations; circular, multiunit length, single-stranded, lariats, 
loops and large replicating forms [12]. Similarly, 2D DNA gels show highly 
branched DNA products [89]. Replicating HSV-1 DNA cannot be 
monomerized using restriction enzymes and most replicated DNA is unable 
to enter pulsed-field gel electrophoresis [90]. The extensive branching as well 
as the equimolar configurations of the genome suggests a high degree of HR 
in the replicating HSV-1 DNA. However, mutant virus, containing deletions 
of the internal inverted repeats at the junction between the UL and US, 
produce viable progeny of only one isoform [91].  
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1.3 DNA Recombination 
Recombination between homologous DNA strands is an error-free repair 
pathway for dsDNA breaks employed when a homologous sequence is 
available e.g. during DNA replication. As ssDNA nicks and gaps in the DNA 
template are readily converted to dsDNA-breaks during DNA replication it is 
reasonable to assume a tight coupling between DNA replication and 
homologous recombination [92]. 
1.3.1 Homologous recombination in E. coli  
The majority of DSB in E. coli is repaired through RecBCD-pathway. 
RecBCD contains a 3’→5’ helicase (RecB), a 5’→3’ helicase (RecD), a 
sequence-specific recognition of Chi-site (RecC) and a 3’→5’/5’→3’ 
exonuclease (RecB). This complex will degrade the dsDNA end until a Chi-
site is found whereupon RecC binds the Chi-sequence, RecD helicase halts, 
5’→3’ exonuclease of RecB increase its activity and a 3’-overhang will be 
released and loaded with RecA [93]. RecA forms a nucleoprotein filament of 
the 3’-overhang in a 5’→3’ direction and disassembles in the same order. 
RecA bound to ATP invades homologous sequence by base flipping [94]. 
Structures of recombination intermediates have been elucidated by X-ray 
crystallography [95]. ATP-hydrolysis is required for disassembly, bypass of 
heterologous sequence and strand exchange >3kb in length [96]. Following 
strand invasion, a Holliday junction consisting of four strands will form and 
migration is mediated by a tetramer of RuvA, which interacts directly with 
DNA and manages base-pair rearrangements, and RuvB that functions as the 
motor protein. Together, RuvAB drives branch migration preferably in a 
5’→3’ direction. To repair double-stranded breaks Holliday intermediates are 
established in both sides of the break and residual gaps after recombination 
are filled by DNA synthesis. Finally RuvC endonuclease resolves the 
junction [97].  
1.3.2 Eukaryote 
DSB can arise from e.g. DNA-damaging chemicals, ionizing radiation or 
nuclease activity. Repair of DSB is essential and failure to complete this type 
of repair often results in apoptosis. Most of the studies in DSB-repair has 
been done in yeast models [98]. Three major pathways are thought to mainly 
responsible for the repair of DSB in eukaryotic cells; a non-homology-driven 
non-conservative pathway, NHEJ, a non-conservative homology-driven 
mutagenic pathway, SSA and, a homology-driven non-mutagenic pathway, 
HR (Figure 8) [99]. Besides these established pathways, two of them with 
clear physiological function, NHEJ in VDJ-recombination and HR in 
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meiosis, other less well characterized repair-mechanisms using similar 
machineries have been suggested, such as micro-homology mediated end-
joining and alternative-NHEJ. Competition between repair pathways and 
preference of method depends upon cell type and stage as well as availability 
of proteins and sister chromatids [100, 101]. 
Figure 8. Three major DSB repair pathways. (a) NHEJ. (b) SSA. (c) HR. Printed 
with permission (Vasileva 2005).  
Non-Homology End-Joining 
NHEJ is considered to be the most prominent DSB repair pathway in non-
dividing cells. DSB-ends are recognized by Ku heterodimer and brought 
together by DNA-PKcs and polished by nuclease/polymerase e.g. Artemis to 
finally be ligated by DNA ligase IV/XRCC4/XLF [102]. NHEJ results in an 
altered DNA sequence and it is not suitable for repair in coding sequences. 
Single-Strand Annealing 
DSB-ends are recognized by the MRN-complex (MRE11-RAD50-NBS1), 
which has been described as a molecular Velcro that brings together DNA-
ends [103]. MRE11 contains a 3’→5’ exonuclease and an endonuclease 
activity. It has been suggested that dimerized MRE11 holding two ends of a 
DSB could facilitate micro-homology dependent joining [104]. RAD50 is the 
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proposed “fishing rod” which protrudes from the DNA-ends in search of a 
matching partner. It contains ATP-binding domains at the ends, a hinge 
containing a zinc hook in the middle responsible for homomeric interaction 
and long coiled-coil regions flanking the flexible hinge [103]. NBS1 
(Nijmegen breakage syndrome 1) contains phosphopeptide-binding domains 
for interaction with other components in signalling and repair and have been 
shown in conjunction with NHEJ-complex during VDJ-recombination [100]. 
Since MRE11 has an exonuclease in the opposite direction, the responsible 
exonuclease for creating a free 3’-end is most likely EXO1 or BLM-DNA2 
[105]. The exposed ssDNA is then stabilized by RPA, annealing is carried 
out by RAD52 and ends are cleaved by ERCC1/XPF [105, 106]. RAD52 
exists in a heptameric ring shape and has a circular positively charged DNA 
binding groove that interacts with the phosphate-backbone of DNA. It has 
been suggested to mediate annealing of ssDNA possibly by rolling motion of 
RAD52 rings [107]. Intriguingly the MRN-complex is inactivated by the 
adenovirus oncoprotein E4orf3 and the E4orf6-E1b55K complex in order to 
prevent formation of adenovirus DNA concatemers during virus replication 
[108]. 
Homologous Recombination 
Similar to the SSA repair pathway a 3’-filament is essential for initiating the 
process. RPA-binding stabilizes ssDNA, but blocks at the same time RAD51 
recombinase from binding. This block is ameliorated by a huge protein (3418 
amino acids), BRCA2 (BReast CAncer susceptibility gene 2), which has a 
DNA-binding C-terminal and RAD51-binding domains in the middle region. 
Mutations in BRCA2 are known to cause breast and ovary cancer. BRCA2 
binds up to eight RAD51 molecules and enhance their ability to bind to 
ssDNA, reduce their ability to bind dsDNA, reduce their ATPase activity and 
assists in displacement of RPA. BRCA2 interacts with BRCA1 for which the 
function still is unclear [109, 110]. RAD51 binds dsDNA and ssDNA, the 
latter with higher affinity. It has a low ssDNA-dependent ATPase activity 
and forms nucleoprotein filaments in a 3’→5’ direction, covering 3bp per 
monomer. Short strand-exchanges are dependent on ATP and Mg2+, and are 
stimulated by RPA addition, but RAD51 is unable to perform longer (3kb) 
strand exchanges in vitro by itself. RAD51 can also facilitate end-to-end and 
end-to-tail ligation of DNA-substrates, which might explain its presence in 
high concentration in lymphoid tissue where NHEJ is a prominent pathway 
[111]. Interestingly, in contrast to yeast, RAD51 mutations in mice are 
embryonically lethal and greatly impair proliferation [112]. RAD51 paralogs 
such as RAD51B, C and D share sequence similarities and have been found 
on filaments as well as in Holliday junctions, but exact roles for these 
proteins are still elusive [109]. Subsequent annealing is mediated by RAD52. 
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Branch migration of the Holliday junction have been shown to be carried out 
by several potential proteins e.g. RAD54, BLM and RECQ1, which 
preferably drive the migration in a 3’→5’ direction. RAD54 lacks helicase 
activity, but is able to perform branch migration through longer stretches of 
heterology in comparison to BLM and RECQ1 [113, 114]. In contrast to 
RAD51, RAD54 knockout mice are viable, but display sensitivity for 
ionizing radiation [115]. Resolving the Holliday junction can be carried out 
by a number of nucleases e.g. MUS81-EME1, GEN1 and SLX1-SLX4, and 
is often dependent on interaction with branch migration proteins [116]. 
1.3.3 HSV-1 
Replication of HSV-1 DNA has been shown to be tightly coupled to DNA 
recombination as well as DNA repair. Upon entry of the HSV-1 genome into 
the nucleus, the DNA is immediately circularized by DNA ligase IV/XRCC4, 
which are involved in NHEJ [14]. DNA isolated from virus particles contains 
a large number of nicks, gaps as well as ribonucleotides randomly located on 
both strands suggesting that DNA repair may have to precede DNA 
replication in newly infected cells. [117, 118]. During the replicative phase (8 
hpi), incorporation assay using radiolabeled nucleotides showed that 40% 
was incorporated into replicating DNA and 30% was incorporated into viral 
DNA undergoing repair [12]. The ND10 formed after viral infection have 
been shown to contain DNA repair proteins such as RPA, Rad51 and NBS1 
[119]. Using UV-irradiated HSV-1, it was shown that transcription-coupled 
repair, nucleoside-excision repair and HR are essential for propagation of 
these viruses [120]. It has also been observed that HSV-1 infection increases 
SSA-mediated repair 2-fold of a genome-integrated reporter-gene. In the 
same study, infection led to a reduction of HR and NHEJ with analogous 
reporters [68]. However, reporter plasmids containing linearized a-sequences 
at the ends displayed SSA-like repair in ERCC4-deficient cells and a-
sequences have shown to increase recombination frequency two-fold in a 
similar assay [121, 122].  
HSV-1 has its own uracil glycosylase, UL2, which is thought to be associated 
to UL30 and possibly carry out replication-coupled base-excision repair 
[123]. ICP8 has been shown to share some properties with classical 
recombinases such as RecA and Rad51 mentioned above. ICP8 has been 
shown in vitro able to melt and anneal dsDNA as well as efficiently transfer 
ssDNA from a dsDNA template to an ssDNA circle with the same sequence 
[66, 124, 125]. ICP8 has also been shown to work in conjunction with the 
5’→3’ exonuclease, UL12, also known as the alkaline nuclease [126]. It has 
been shown that UL12 interacts with the MRN-complex [127]. HSV-1 UL12 
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null-mutants propagate poorly, but with only minor impairment of DNA 
replication, and genomic inversion appears to be undisturbed [90, 128]. UL12 
protein has been shown to enhance SSA of integrated gene-reporter in 
conjunction with Rad52 or ICP8. However, SSA has not been shown to occur 
in the HSV-1 genome in itself [68].  
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1.4 RNA transcription 
1.4.1 Transcription initiation 
Eukaryotic RNA polymerase II (pol II) transcription is separated into three 
stages; initiation, elongation and termination. The initiation process starts at 
the promoter DNA-sequence elements e.g. TATA-box, BRE (TFIIB 
recognition element), Inr (initiator) and DPE (downstream promoter element) 
[129]. However no promoter contains all elements and many promoters 
contain one or none of these sequences. The global transcription factors 
TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH are required for all pol II 
transcription, but variations of subcomponents can be found depending on the 
sequence of the promoter [130]. The order of global transcription factors 
recruitment to a model promoter is initiated by the binding of TFIID, which 
is built up by TBP (TATA-binding protein) and ~14 TAFs (TBP-associated 
factors). TBP will bind the TATA-box in the promoter and will induce a 
sharp bend in the DNA, which will facilitate the forthcoming interactions. 
Next TAF1 and TAF2 will bind the Inr and TAF6 and TAF9 will bind the 
DPE [131]. TFIIA will then bind to TFIID and stabilize the DNA-TFIID 
complex and block transcriptional inhibitors. TFIIB will be recruited to bind 
BRE. A motif in TFIIB, the B-finger, will later be inserted into the exit 
channel for newly synthesized mRNA in pol II and thereby regulating the 
promoter clearance of pol II. TFIIF will bind pol II and escort it to the other 
bound factors and finally TFIIE and TFIIH will join the complex [132]. 
These components together are called the pre-initiation complex and 
recruitment of factors for initiation is thought to be the rate-limiting step for 
transcription [133]. Components of TFIIH includes helicases XPB and XPD, 
which will facilitate the initial melting of the DNA-duplex, and a kinase 
component, CDK7, which will phosphorylate one of the twelve subunits of 
pol II, Rbp1, on the Serine-5 residue of the CTD (C-terminal domain) and 
this event will kick-start the pol II to leave the pre-initiation complex and 
begin the transcription [132]. The CTD contains dozens of repeats of a 
heptapeptide with the sequence Y1S2P3T4S5P6S7. It is thought to function like 
a scaffold for signalling and interactions, such as splicing factors and DNA-
repair, by modulation of the amino acids either by phosphorylation (tyrosine, 
threonine or serine) or isomerization (proline). Stimulation of initiation by 
phosphorylation of Serine-5 and elongation by phosphorylation of Serine-2 
appears to be conserved throughout eukaryotes. Other CTD-patterns appears 
to be less general and elusive [134, 135]. 
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1.4.2 Transcription elongation 
During elongation a Positive Transcription Elongation Factor b (P-TEFb), 
consisting of CDK9 and CyclinT is recruited to the initiated pol II. 
Phosphorylation by CDK9 of CTD at Serine-2, and the evolutionarily 
conserved transcription factor SPT5, which together with SPT4 forms the 
elongation complex DSIF (DRB Sensitivity Inducing Factor), establishes the 
elongating complex [136]. Interestingly DSIF is the only transcription 
elongation factor conserved in all three domains of life. Crystallization 
experiments in yeast and archea have shown that Spt4 and Spt5 closes the 
RNA polymerase clamp surrounding the transcribed DNA and interacts with 
upstream DNA as well as the non-template strand during transcription [136, 
137]. The C-terminal domain of Spt5 has been suggested to interact with 
nascent RNA at the exit tunnel from RNA polymerase [137]. As the complex 
transcribes towards the 3’-end, maintenance and expansion of Serine-2 is 
carried out by CDK12 in complex with CyclinK. The location of CDK9 and 
CDK12 at opposite end of transcribing genes have been shown convincingly 
using ChIP-Seq [138, 139].  
1.4.3 Promoter proximal stalling 
Many human genes regulate transcription at the elongation phase by 
activation of a stalled pol II. This has been extensively studied for heat shock 
protein 70 and HIV-1 [140, 141]. The negative elongation factors, NELF A-E 
binds through DSIF to pol II and have been shown to pause the complex and 
await a signal for continued transcription. In the case of HIV-1, pol II is 
activated by the viral protein Tat (Trans-Activator of Transcription) in 
collaboration with P-TEFb [142]. CDK9 phosphorylates the NELF-complex, 
which then dissociates from the transcription complex, Serine-2 on CTD, and 
SPT5, at which transcription is resumed [143].  
1.4.4 Transcription termination and export 
Transcription termination is initiated by the recognition of the highly 
conserved polyadenylation signal AAUAAA by CPSF 
(Cleaveage/Polyadenylation Specific Factor). CPSF has been shown to 
interact with TFIID as well as CTD and can be found at the beginning and the 
end of transcription [144]. Downstream of the polyA-site, a U/GU-rich 
sequence is recognized by CstF (Cleavage stimulating Factor). Together in a 
complex, CPSF, CstF, CTD of pol II, PAP (poly-adenylation polymerase) 
and CF (Cleavage Factor) Im and IIm, a cleavage is induced at the poly-A site. 
Further polymerization will only require CPSF, PAP and a poly-A binding 
protein PABII. Export of nascent mRNA has shown to be linked to splicing 
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by binding of hnRNP-complexes  [145]. However many viruses such as 
HSV-1, hepatitis B virus and HIV, as well as intronless genes in human cells, 
contain cis-acting sequence elements in nascent mRNA which promotes 
export and poly-adenylation [146]. 
1.4.5 HSV-1 transcription 
HSV-1 utilizes the pol II to express its genes. It was observed that 
transcription of HSV-1 genes could start in the absence of any protein 
synthesis by adding cyclohexamide to infected cells [147]. Following up on 
this observation a combination of cyclohexamide and actinomycin D was 
used at different time-points [148]. By infecting cells at an MOI of 20 the 
results showed three distinct temporal groups of ICP (Figure 9).  
Figure 9. HSV-1 transcription. Sequential activation of HSV-1 alpha/Immediate 
Early, beta/Early and gamma/Late genes. 
The alpha group (also known as Immediate-Early genes) are transcribed 
without prior protein synthesis and the protein products are synthesized at 
highest rates from 3-4 hours post-infection and at diminishing rates 
thereafter. VP16 (UL48) which is delivered to the cell through the 
incorporation of the tegument to the cytoplasm activates transcription of the 
alpha genes by associating to the cellular protein HCF-1. Together this 
complex binds to Oct-1 and recognizes the motif TAATGARAT present 
upstream in the promoters of alpha genes [20]. The complex will then recruit 
transcription factors and the pol II. Five of the six alpha genes regulate 
expression of themselves as well as the beta and gamma genes. The alpha-
proteins ICP0 and ICP4 are required for activation/derepression of 
transcription of the next set of genes, the beta-group (also known as Early 
genes) [149]. The beta-proteins are synthesized at highest rates from 5-7 
hours post-infection and at decreasing rates thereafter. The majority of the 
beta genes encode replication proteins (Table 1), and the DNA replication 
process does in turn activate the gamma-group (also known as Late genes). In 
later studies the gamma-group was subdivided into gamma1 and gamma2, 
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and they have the kinetics of moderate synthesis or low to no synthesis prior 
to replication respectively. The gamma-proteins represent the majority of the 
structural proteins. Upon DNA replication the transcription of the gamma-
genes is greatly amplified. Besides DNA replication, the viral proteins ICP0, 
ICP4, ICP22 (US1.5) and ICP27 are required for proper expression of 
gamma genes, however the mechanisms have not been completely elucidated 
[3]. This remarkable order of transcription allows the virus to first produce 
the DNA before producing the structural components in which the DNA will 
be packaged into. 
ICP0 contains a RING domain, which functions as an E3 ligase, indicating a 
role in ubiquitination of target proteins. ICP0 is thought to indiscriminately 
activate viral genes by derepression of histones bound to the viral genome 
[3]. It is proposed that ICP0 carries out this function by inhibiting HDAC 
(histone deacetylase) and mutant virus with ICP0-deletions have been shown 
to be partially rescued by HDAC-inhibitors [150]. ICP4 is considered to be 
the main activator of post-alpha genes and is required for all beta and gamma 
genes [149]. ICP4 has a sequence-specific binding domain, which appears to 
correlate with repression of its own gene and ORF P. Non-sequence specific 
binding however appears to correlate with trans-activation of beta and 
gamma genes. By binding to promoters and interacting with transcription 
factors and the mediator complex ICP4 stimulates transcription together with 
other viral proteins. ICP22 encoded by the US1 gene, which also encodes a 
truncated C-terminal version US1.5 has been shown to be required for 
appropriate expression of certain gamma genes and has been shown to be co-
localized with pol II [151]. Another important viral factor for post-alpha gene 
expression is ICP27. Mutant virus with ICP27 deletions lead to less beta- 
(UL29 and UL42) and gamma-gene expression and a virus mutant carrying a 
truncated version of ICP27 lacking the last eight amino acids in its C-
terminal tail is deficient in expressing gamma-genes despite seemingly 
normal replication [152, 153]. ICP27 has been proposed to be the link 
between replication and late gene expression by its ability to interact with 
ICP8 and CTD [154, 155]. The effect ICP27 has on gene expression is 
through its inhibition of host expression by inhibiting splicing and its post-
transcriptional role mediating mRNA export and enhancing poly-adenylation 
of transcripts [156]. ICP27 mutants that are unable to interact with mRNA 
nuclear export factors have been shown to have a general effect on poly-A 
transcript accumulation in the nucleus [157].  
Replication-coupled transcription 
The notion that the separation of DNA-strands during replication can increase 
transcription is puzzling and several factors have been described to be 
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essential for this process in different organisms. This phenomenon is found in 
RNA and DNA-viruses as well as eukaryotic cells. In Saccharomyces 
cerevisae 3.5% of 4270 genes are directly regulated by DNA replication and 
in human cells a set of replication-dependent histones have been extensively 
studied [158, 159]. Many different mechanisms have been suggested to be 
responsible for replication-coupled transcription such as; addition of a factor, 
removal of a factor, cell cycle stage, increased copies of promoter and 
replacement of modified nucleotides.  
It has been shown in vitro in the T4-phage system that the sliding clamp 
protein gp45 left behind on the lagging strand interacts with the RNA 
polymerase-bound gp33 and gp55 to elicit transcription. The transcription 
direction is decided by which strand that contains the ssDNA nick [160]. 
Human viruses e.g. adenovirus, Epstein-Barr virus (EBV), human 
papillomavirus (HPV) and SV40 also display replication-coupled 
transcription. Inhibition of replication with chemical inhibitors, super-
infection with similar viruses and the use of temperature-sensitive mutants 
with defects in replication proteins have often been used to study this 
phenomenon [158, 161, 162]. In the adenovirus system, removal of an 
inhibiting factor by replication is one of the mechanisms for replication-
coupled transcription. Transcription of the adenoviral gene IVa2 is normally 
inhibited by binding of IVa2-RF, which exists at saturating levels before 
replication. With the increase of genomes during replication the unbound 
genomes will be able to transcribe the IVa2 gene [163]. Switch from early to 
late transcription by transcriptional regulation has been described in 
adenovirus and HPV. Adenovirus E4orf4 has been shown to mediate the 
early to late switch by dephosporylation of cellular SR proteins and thereby 
modulating splicing and HPV-16 E2 inhibit termination at an early poly-
adenylation signal and result in a readthrough to the late poly-adenylation 
signal [164, 165].  
HSV-1 gamma gene expression can be inhibited by addition of replication 
inhibitors. In order to show that activation of gamma2-genes in fact are 
activated by DNA replication in cis and not by trans-activating factors 
Roizman and colleagues sequentially infected cells using viruses containing 
promoters representing the three different temporal classes coupled to the 
thymidine kinase (tk) gene. Cells infected with tk-null mutant virus were 
superinfected with a gamma2-tk mutant virus at a time point when the first 
virus had started its replication. By measuring the tk-activity they found no 
trans-activating factors sufficient for inducing a gamma2-tk production [166].  
Characterizations of the gamma2-genes have mainly been focused on UL38 
and gC (UL44). It has been observed that many gamma2-genes have 
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exchangeable downstream activation signals, which have been shown to be 
associated with a component of TFIID [167-169]. It has also been shown that 
a cell line containing a temperature sensitive mutant version of TAF250, the 
major component of TFIID is required for gamma2 gene transcription [170]. 
Also, an ICP4-mutant virus with 2/5 of its C-terminus removed is unable to 
interact with TAF1 and TFIID in vitro and is unable to induce gamma-gene 
transcription [171]. The gC-gene contains a cis-acting sequence that 
functions as a negative regulative silencing element which requires ICP27 to 
overcome [172].  
Organization of genes such as UL29 and UL30 which flank oriL in a 
divergent fashion (also seen in SV40, polyomavirus, bovine papillomavirus 
1, adenovirus and EBV) as well as the direction of beta genes in relationship 
to oriL indicate functional coupling between replication and transcription 
[173-175]. This arrangement removes the possibilities for a head-to-head 
collision between replication and transcription of beta genes on UL and is 
believed to prevent replication fork collapse [176]. In stark contrast the 
gamma genes are distributed randomly in both directions relative to the 
replication origin. 
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2 RESULTS AND DISCUSSION 
2.1 Paper I 
In the herpesvirus-family only the alphaherpesvirus and the roseolovirus of 
the betaherpesvirus have the origin binding protein (Figure 1). To 
characterize the binding of C-terminal OBP (OBP) to the origin sequence 
oriS in vitro we created truncated versions as well as mutant variants of 
OBP. Different truncated versions of OBP displayed diverse solubility and 
binding capacity. A minimal construct containing amino acids 536-813 was 
needed to obtain a soluble protein which binds oriS in electromobility shift 
assays (EMSA). Conserved amino acids in the N-terminus of this truncated 
version contain a conserved F553XXKYL-motif. The lysine in this motif is 
mutated into an alanine in a temperature-sensitive mutant virus [177]. A 
phylogenetic analysis of OBP-sequences revealed conserved regions in the 
C-terminal domain as well as the absolute C-terminal tail. The C-terminal 
domain of OBP in alphaherpesviruses contains the motif R756VKNL and 
site-directed mutagenesis replacing the arginine, lysine or leucine with 
alanine greatly reduced the binding capacity to oriS, while replacing the 
valine or asparagine had little or no effect on binding. Additional replacement 
with alanines of a conserved phenylalanine-751 upstream and two leucines-
768/769 downstream of RVKNL also displayed impaired binding while 
mutations of upstream of a proline-glycine-752/753 dipeptide only reduced 
binding moderately. With the exception of CHV1 (cercopithecine herpes 
virus 1) the recognition sequence in oriS is TTCGCAC, which in CHV1 is 
TCCGCAC. Expressing both HSV-1 and CHV1 OBP we examined the 
binding properties of these proteins to respective oriS-sequence, however no 
difference was found in the binding affinity to either oriS-sequence. Together 
our results define a series of conserved amino acids, in particular the 
RVKNL-motif required for sequence specific binding of DNA. On the other 
hand the FXXKYL-motif seems to be required for stable folding. 
The absolute C-terminus of OBP is known to interact with ICP8 and 
conserved amino acids form the motif WPXXXGAXXFXXL. By replacing 
conserved amino acids with alanine as above and adding ICP8 to the EMSA 
we showed that the tryptophane and phenylalanine are essential for binding 
while replacement of the proline or phenylalanine did not affect the 
interaction. Interestingly, replacement of the HSV-1 OBP C-terminus with 
the varicella-zoster virus version still preserved the interaction albeit with 
altered mobility in the gel. This C-terminus interaction with ICP8 is absent in 
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the OBP of distantly related alphaherpesvirus that infects birds, gallid 
herpesvirus (GHV1) and psittacine herpesvirus (PsHV1), and sea turtles, 
Chelonid fibropapillomatosis herpesvirus (CFPHV), as well as the human 
betaherpesvirus (roseolovirus) HHV6A, HHV6B and HHV7. Interestingly, 
when studying the origin of replication for all alphaherpesvirus, these six 
distantly related viruses as well as VZV and CHV9 do not have the ability to 
form a BoxI-BoxIII hairpin (Figure 5). Furthermore, computational 
phylogenetic analysis using multiple sequence alignment of all OBP-
sequences unbiasedly assigned these eight viruses into three separate 
evolutionary branches. NMR-experiments revealed that ssDNA oligo 
containing the oriS-sequence indeed form stable B-DNA conformation 
hairpin-structures. 
To conclude, it appears that the evolutionary development of the OBP-oriS 
and OBP-ICP8 interaction has evolved in a stepwise manner. From an 
original herpesvirus, the first step appears to be the separation between 
betaherpesvirus (roseolovirus) and alphaherpesvirus, during which the 
RVKNL-motif in OBP was acquired and made possible the sequence specific 
binding to TTCGCAC in oriS. The following step involves the development 
of the C-terminus interaction with ICP8 found in all alphaherpesvirus except 
for GHV1, PsHV1 and CFPHV. A final step, separate from the ancestor of 
VZV and CHV9, a subset of herpesvirus acquired a hairpin in the oriS-
sequence (Figure 10). These steps display a mechanistic co-evolvement that 
might be coupled to biological changes such as host cell selection and 
establishing an evolutionary niche. 
Figure 10. Stepwise evolution of OBP and oriS. From the ancient herpesvirus 
containing OBP (bottom), the first branching occurred with the 
alphaherpesvirus acquisition of the binding capacity to oriS. Subsequent 
branching followed with the acquisition of binding properties to ICP8 and a 
hairpin-structure in the oriS. 
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2.2 Paper II 
In this study we focused on homology-driven recombination in HSV-1. 
Firstly we indirectly studied the isomer population (Figure 4) of HSV-1 by 
co-infecting two different temperature sensitive mutant viruses. Mutant virus 
tsK harbours mutations in the ICP4 gene located at the terminal repeats of US 
and the tsS virus contains mutations in the UL9/OBP gene (Figure 11). 
Theoretically if a cell would be infected by one virus of each strain and the 
viruses would undergo infinite number of recombination the chances to 
produce a non-temperature sensitive wild type virus would be 25% (i.e. 
carrying the UL9 from tsK and the ICP4 from tsS). We employed this assay 
using a control cell line as well as a cell line, GM16097, derived from a 
patient with a deficiency in ligase I function, resulting in a retarded ligation 
of Okazaki-fragments and aberrant DNA repair [178]. We measured the 
number of recombined progeny displaying wild type features i.e. replicating 
at the non-permissive temperature. For both cell lines the recombination rate 
was 17%. The inability to reach the maximum theoretical rate of 
recombination is most likely due to different replication foci in the nucleus 
and a Gaussian distribution that leads to unequal number of viruses infecting 
the same cell. In order to examine whether the recombination proteins Rad51 
and Rad52 are involved in this recombination assay we pre-treated the cells 
with siRNA directed against these proteins. Rad51-knockdown reduced 
recombination rates to 11% in wild type cells and to 3% in GM16097 cells. 
Rad52-knockdown reduced recombination rates to 5% in both wild type cells 
and GM16097 cells. These results indicate that both Rad51 and Rad52 are 
essential in the recombination between the UL and US, however, regarding the 
differences between the cell lines the data should be interpreted with caution 
since knock-down levels vary from cell lines and experiments. 
Secondly we studied the recombination within a 3kb region of US by co-
infecting the cell types mentioned above with three viruses harbouring 
different restriction enzyme markers in the region of interest. By isolating 
329 plaques of the virus yield and subsequent PCR reactions of the specific 
regions, isolates were classified as recombinants or non-recombinants [179]. 
For a few isolates we also performed sequencing for validation. In the wild 
type cells 2% of the virus progeny were classified as recombinants, and in 
GM16097 cells 12% were recombinants, indicating that the increased 
amounts of single-strand nicks available on the HSV-1 replicating DNA 
correlates with increased recombination, most likely serving as 
recombination substrates. 
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Finally we studied a 21-nucleotide tandem repeat in the US7 gene which has 
been shown to vary between strains and also within the same infected 
individual implying that this region might be highly prone for recombination. 
Virus yield from the 3kb recombination assay mentioned above was passaged 
ten times at which recombination rates were 9% in wild type cells and 30% in 
GM16097 cells. Tandem repeats were calculated by measuring PCR product 
lengths. Unexpectedly we found no recombinants within the tandem repeat 
region in 20 plaque-isolated viruses. Intra-viral uneven recombination events 
of the tandem repeat region was simultaneously studied by infecting cells at 
low multiplicity of infection and passage of progeny 25 times. No 
recombinants were found under these premises either, indicating that 
recombination events leading to variable number of repeats is a rare 
occurrence in cell-based assays. 
Figure 11. HSV-1 genome and markers for recombination experiments. (A) 
The tsS mutation is mapped to the UL9 gene and the tsK mutation is mapped to 
the ICP4 gene. A cluster of glycoprotein genes containing gG (US4) and gI 
(US7) in the US segment is separated by 3kb. (B) Enlargement of the 
glycoprotein gene cluster. The location of the 21 nucleotide tandem repeats is 
highlighted. Restriction enzyme polymorphism between the clade A (no cuts), B 
and C is shown under respective PCR-fragments. 
In conclusion we have described DNA recombination of HSV-1 at three 
different levels of the genome. We have shown that Rad51 and Rad52 are 
important for interviral recombination, that single-strand nicks are most 
 28 
 
likely recombinogenic and that tandem repeat expansion/contraction are rare 
events. These assays could serve as future models for studying DNA 
recombination by using mutated cell lines and experimental use of knock-
down/knock-out technologies or inhibitors. Such studies may yield important 
insights into mechanisms and regulation of homologous recombination in 
mammalian cells. 
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2.3 Paper III 
We started our studies on replication-coupled transcription in HSV-1 by first 
looking at the recruitment of pol II to the different classes of promoters 
(alpha, beta and gamma). Using tsK and tsS (described in the previous 
section), occupancy on model promoters using chromatin 
immunoprecipitation were studied at non-permissive temperatures (i.e. 
without beta and gamma transcription (tsK) and without replication (tsS)). 
We confirmed previous studies that ICP4 was dependent for pol II 
recruitment (tsK) and discovered that pol II was recruited to gamma2-
promoters despite deficient replication (tsS) [180]. Following up on this we 
used the same method to study the pol II occupancy profile on a beta and a 
gamma gene. The gamma gene displayed a retarded occupancy compared to 
the beta gene, but there were no signs of promoter proximal stalling. Using 
DRB (5,6-dichloro-1--D-ribofuranosyl-benzimidazole), an inhibitor of 
CDK9 we showed a prominent specific inhibition of gamma2-gene 
expression with minor effects on beta-genes and DNA replication. 
Continuous DRB-inhibition of CDK9 is required for the full effect and 
addition of DRB at 6hpi, a time-point at which replication has started, still 
blocks gamma2-gene expression. To verify the specific effect of CDK9-
inhibition, DRB- and flavopiridol-titration experiments displayed IC50-values 
of gamma2-genes, but not beta-genes, similar to in vitro assays of CDK9-
inhibition. Also, siRNA-experiments against CDK9 (unpublished data) and 
Spt5 reduced gamma2-gene expression in a similar manner. Despite major 
inhibition on gamma2-gene expression with DRB, measurements of mRNA-
levels using RT-qPCR and RNA-seq displayed minor differences. However a 
two-fold difference was shown in the nuclear/cytoplasm ratio when using 
subcellular fractionation. In summary, pol II-recruitment to gamma2-genes is 
not impaired despite absence of DNA replication. CDK9 and DSIF are 
required for expression of gamma2-genes and are likely to be coupled to 
post-transcriptional mechanisms such as maturation and export.  
How do these results fit into the model of replication-coupled transcription? 
At least two plausible scenarios can be discussed. Firstly, DNA replication 
leads to an addition or removal of a factor at the promoter that allows for 
DSIF to bind to the pol II-complex. Analogous to the T4 phage-system a 
factor such as ICP8 could be left on ssDNA gaps on the lagging strand and 
recruit ICP27 as well as DSIF. In contrast inhibiting factors could be bound 
to a downstream activation sequence in gamma2-genes and these would be 
removed by the DNA replication. Secondly, DNA replication might be 
essential because the gamma2-promoters are extremely weak and expression 
can be detected through the increased number of copies. In this scenario the 
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beta genes would be considered the unconventional genes since they do not 
require DSIF and CDK9. This scenario is supported by the observation that 
plasmids containing gamma2-promoters behave like beta-genes when 
transfected. Alpha genes might still require CDK9 and DSIF to some extent 
and this might explain why we observe a slight retardation in the recruitment 
of pol II and DNA replication.  
Regardless of the coupling to DNA replication our data shows that gamma2-
genes produce a transcription-complex that recruits CDK9. CTD and/or DSIF 
and/or ICP27 phosphorylation most likely provide the appropriate scaffold 
for maturation factors for mRNA-capping, transcription termination and 
mRNA-export, which seems to circumvented in beta genes by another 
mechanism. DSIF has been shown to be a processivity factor in mammalian 
genes for transcription of longer transcripts. This is however not the case for 
HSV-1 genes where beta genes generate relatively long transcripts. Further 
characterization of the transcription complex of beta- and gamma2-genes 
seems to be the appropriate step to elucidate the mechanism. The difficulty of 
separating the different pol II-complexes during an infection and the absence 
of a plasmid-based in vivo system could perhaps be overcome by creating an 
(alpha and) beta-free virus using bacterial artificial chromosomes and 
complementing them with stably transfected plasmids containing essential 
proteins for transcription and replication, but under different promoters. 
It has been suggested that DRB exerts it effect through ICP22 and UL13, 
which together increase the transcription of a subset of gamma genes such as 
UL38. The evidence that these two proteins are involved has been shown by 
immunofluorescence where mutants lacking ICP22 or UL13 display reduced 
co-localization between CDK9 and pol II. In contrast to our results this study 
do not find any inhibition of gamma-genes gB, gC and gD in the presence of 
DRB [151]. It is an interesting alternative explanation model, but it would not 
explain how we in our experimental setting find clear reduction in all five 
tested gamma-genes and that no specific gamma mRNA-reduction is found in 
the transcriptome of infected cells.  
It is tempting to speculate whether CDK9-inhibitors could be a complement 
in the antiviral arsenal. Inhibition of virus propagation in cultured cells could 
be visualised with the viral cytopathic effect using light microscopy. We have 
shown that 25M DRB is sufficient to inhibit the cytopathic effect and GFP 
expression of a recombinant HSV-2 gG2-GFP virus (Figure 12). DRB has 
also been shown to inhibit transcription elongation in adenovirus [181]. In a 
recently published study, a CDK9-inhibitor was efficiently employed to 
inhibit the propagation of HSV-1, cytomegalovirus and adenovirus in cell 
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cultures. The same inhibitor was also shown effective for treatment of HSV-1 
infected mice, more inspiringly it was efficient even in mice infected with an 
acyclovir-resistant HSV-1 strain [182]. Considering that flavopiridol has 
passed phase II trials, clinical data regarding chronic virus infections would 
be interesting to study in the treated patient groups [183]. 
 
Figure 12. DRB inhibits cytopathic effect and HSV-2 gG2-GFP fusion protein 
expression. Human fibroblast cells were infected with recombinant HSV-2 gG2-
GFP in absence or presence of DRB for 18 hours. Bright field microscopy in 
left column shows cytopathic effect and right column GFP-fluorescence. 
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3 CONCLUSIONS 
3.1 Paper I 
 A minimal soluble version of HSV-1 OBP which binds to 
oriS contains the amino acids 536-813.  
 The evolutionary divergence of OBP-oriS has developed 
stepwise with the acquisition of an RVKNL-motif that binds 
to oriS, a C-terminus ICP8-interacting motif and finally an 
ability to form a hairpin in the oriS-sequence. 
3.2 Paper II 
 Rad51 and Rad52 are involved in isomeric HSV-1 
recombination. 
 Mutant cell line with increased amounts of ssDNA nicks 
display high rate of HSV-1 recombination events. 
 Expansion or contraction of tandem repeats in US7 is rare 
despite high recombination frequency in surrounding 
sequences. 
3.3 Paper III 
 RNA polymerase II is recruited to gamma2-gene promoters 
even in the absence of DNA replication. 
 CDK9 and DSIF are required for gamma2-gene expression. 
 Only minor differences in the HSV-1 mRNA expression 
profile can be observed when inhibiting CDK9 with DRB.  
 DRB-inhibition leads to accumulation of HSV-1 mRNA in 
the nucleus indicating a post-transcriptional role for CDK9. 
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